Invention Grant
- Patent Title: Heterocyclic compound
- Patent Title (中): 杂环化合物
-
Application No.: US14379343Application Date: 2013-02-19
-
Publication No.: US09085578B2Publication Date: 2015-07-21
- Inventor: Hiroyuki Nagamiya , Masato Yoshida , Masaki Seto , Shogo Marui , Tsuneo Oda , Yuji Ishichi , Hideo Suzuki , Tomokazu Kusumoto , Takatoshi Yogo , Chul Yun Rhim , Cheolhwan Yoon , Gil Nam Lee , Hyun Bin Kang , Kwang Ok Kim , Hye Sun Jeon
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2012-034440 20120220
- International Application: PCT/JP2013/054054 WO 20130219
- International Announcement: WO2013/125543 WO 20130829
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/437 ; C07D471/04 ; C07D519/00
Abstract:
The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action.The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
Public/Granted literature
- US20150045349A1 HETEROCYCLIC COMPOUND Public/Granted day:2015-02-12
Information query
